Question Bank › Constraint-side candor

Constraint-side candor

Constraint-side candor: management freely details what it cannot yet do while demand is not the question

Calls Tested
500
Answered YES
31
Hit Rate
6.2%
rare by design

The GEO Group, Inc. (GEO) — this company's answers

NO on the Q2 2016 call 2016-08-02 B+
The model's full reasoning — Q2 2016 call → NO我们根据提供的财报电话会议记录，判断管理层是否自愿且具体地详细说明了公司自身的当前限制（无法生产、服务、配备人员、交付或处理的内容），同时明确表示对其所售产品的需求不是问题，并将这种坦诚与已经进行的实际补救措施相结合。 检查三个条件： 1. 具体自我识别的限制：管理层是否主动、具体地指出公司目前无法做到或无法充分做到的事情（缺乏产能、无法快速填补的角色、尚未准备好的系统或设施、无法达到的产出、无法服务的订单）？ 2. 需求被视为存在且已确定：公司无法完全服务的业务是真实且当前的（订单、客户、承诺的工作或已到达的数量），因此限制是针对实际业务而非假设增长。 3. 正在进行的修复：管理层是否描述了为消除每个已指出的限制而已经进行的具体工作（建设、招聘、调试、认证），作为正在执行而非计划中的？ 在记录中，管理层讨论了各种项目激活、扩张、合同等。他们提到了“闲置设施”（idle facilities）约3000个床位，并正在努力重新部署。他们提到了“北湖设施”（North Lake facility）目前未实现现金流为正，并正在寻找额外客户。他们提到了“卡恩斯住宅中心”（Karnes Residential Center）的扩张和许可。他们提到了“拉文霍尔监狱”（Ravenhall Prison）的建设，该监狱正在按计划进行。他们提到了“ISAP”计划的使用率增加。他们提到了“家庭案件管理计划”（family case management program）的实施。 然而，管理层是否具体指出了公司无法满足的需求？他们提到了“闲置设施”和“北湖”未充分利用，但这是需求不足还是限制？他们提到“北湖”未实现现金流为正，因为主要客户佛蒙特州只使用了约300-350个床位，而设施容量为1748个床位。这似乎是需求不足，而不是无法满足需求。他们提到“闲置设施”约3000个床位，并正在努力重新部署，但这是产能过剩，而不是产能不足。 他们是否提到了无法满足的订单或需求？他们提到了“CAR 16”采购，但那是投标，不是已确认的订单。他们提到了“ICE”的采购，但也是投标。他们提到了“俄亥俄州”和“密歇根州”的机会，但都是潜在的。 他们是否提到了具体的限制，例如无法快速招聘人员、设施未准备好等？没有。他们提到了“拉文霍尔”项目正在建设中，但那是按计划进行，不是限制。 他们是否提到了需求是存在的，但公司无法满足？没有。他们似乎能够满足所有需求，甚至还有闲置产能。 因此，管理层没有自愿且具体地详细说明公司自身的当前限制。他们讨论的是增长机会和项目激活，而不是无法满足的需求。 所以答案应为NO。

← Back to the full GEO analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management VOLUNTARILY AND SPECIFICALLY DETAIL THE COMPANY'S OWN CURRENT LIMITATIONS — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that DEMAND FOR WHAT IT SELLS IS NOT THE PROBLEM, and does management pair that candor with real remediation already underway? Answer YES when management's own account conveys, in whatever form fits the business, ONE coherent posture with all three present: (1) SPECIFIC SELF-IDENTIFIED LIMITS: management itself names concrete things the company currently cannot do or cannot do enough of — capacity it lacks, roles it cannot fill fast enough, systems or facilities not yet ready, output it cannot yet reach, orders it cannot yet serve — described plainly and unprompted rather than extracted defensively; (2) DEMAND TREATED AS PRESENT AND SETTLED: the business the company cannot fully serve is real and current (orders, customers, committed work, or arriving volume already in hand), so the limits are binding against actual business rather than hypothetical growth; and (3) FIXES IN MOTION: management describes the specific work already underway to remove each named limit — building, hiring, commissioning, qualifying — as executing now, not planned. The candor itself is the signal: management speaking like operators cataloguing bottlenecks rather than promoters selling a story. Answer NO if the limitations discussed are excuses for weak demand, competitive losses, or macro softness. NO if the constraints are shortages of purchased inputs with no unserved business of the company's own behind them. NO if management describes limits but no remediation already executing. NO if the discussion is generic ('we are capacity constrained', 'we are investing in growth') without named specific limits. NO if the company is comfortably serving everything asked of it. NO if the posture appears only in analyst questions management does not engage substantively. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
NOAH Noah Holdings Limited Q1 2024 2024-05-30 D
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
GOLD Barrick Gold Corporation Q3 2023 2023-11-02 C
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
TSSI TSS, Inc. Q4 2022 2023-04-03 D
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
PI Impinj, Inc. Q4 2022 2023-02-08 B+
CEIX CONSOL Energy Inc. Q4 2022 2023-02-07 B
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
FORM FormFactor, Inc. Q4 2021 2022-02-02 B
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
HNRG Hallador Energy Company Q3 2021 2021-11-09 C+
HY Hyster-Yale Materials Handling, Inc. Q3 2021 2021-11-06 D
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
ACHC Acadia Healthcare Company, Inc. Q4 2017 2018-02-22 C+
AOSL Alpha and Omega Semiconductor Limited Q2 2018 2018-02-07 B
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
ZBH Zimmer Biomet Holdings, Inc. Q2 2017 2017-07-30 F
PLAB Photronics, Inc. Q2 2017 2017-05-17 C+
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C

How the model reasoned

HY · Q3 2021 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...NO The transcript shows management identifying specific constraints around component shortages and supply chain issues that are limiting production and shipping, with record backlog indicating real demand. However, these limitations are framed as shortages of purchased inputs (components and logistics), which the question explicitly excludes from consideration. The remediation efforts mentioned (expanding teams to secure components) are underway, but the core issue is input constraints rather than the company's own production or operational limits. The candor is present, but it doesn't meet the full criteria for "company's own current limitations" as defined.
CEIX · Q4 2022 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...YES Management voluntarily details specific self-identified limits (staffing challenges preventing full staffing and optimization of CM super sections, supply chain and equipment delays, geological issues) unprompted. Demand is treated as present and settled through actual sales and marketing of coal, with the Itmann project ramp-up delayed despite committed production. Fixes are already in motion via recent changes, focus on staffing two sections, and transition to operations team oversight. This forms a coherent posture of candid bottleneck cataloguing paired with executing remediation.
ACHC · Q4 2017 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...NO The transcript shows management addressing UK-specific constraints (nurse shortages, retrofitting beds, NHS transition delays) and noting real demand elements like census and community needs. However, it does not clearly convey a coherent posture where demand is explicitly treated as settled and unproblematic, with remediation already executing in a specific, 1-2-3 format. The discussion leans more toward operational challenges tied to external factors like NHS processes rather than purely internal limits paired with active fixes. Thus, it does not fully meet the criteria for a YES.

More from the question bank

Physical throughput records at the operatingThe economics improved before the volume arrSmall reported base, oversized already-contrNamed counterparty roster suddenly upgraded Repeat expansion inside the base while new lGeographic or market replication just starteAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.